FBL and prostate cancer: We next determined the extent of nucleolar stress response following platinum-based drugs in LNCaP, PC-3, and 22Rv1 prostate cancer cells by immunofluorescence staining of nucleolar patterns of NPM and Fibrillarin as markers for granular and fibrillar components of the nucleoli, respectively.